Skip to main content
Top

Current Treatment Options in Oncology

Issue 3-4/2009

Content (13 Articles)

Geriatric Oncology

Geriatric Oncology: Introduction

Stuart M. Lichtman

Geriatric Oncology

Adjuvant Chemotherapy for Early Breast Cancer in the Elderly

Mary Leung, Iulianna Shapira, Thomas Bradley, Daniel R. Budman

Geriatric Oncology

Chemotherapy for Ovarian Cancer in the Older Adult

Christopher B. Steer

Geriatric Oncology

Ovarian Cancer Cytoreductive Surgery in the Elderly

Ginger J. Gardner

Geriatric Oncology

NSCLC in the Elderly—The Legacy of Therapeutic Neglect

Jared Weiss, Corey Langer

Geriatric Oncology

Combined Modality Therapy in the Elderly Population

Lilie L. Lin, Stephen M. Hahn

Geriatric Oncology

Bladder Cancer

David J. Gallagher, Matthew I. Milowsky

Central Nervous System Malignancies

The Role of Chemotherapy for Pure and Mixed Anaplastic Oligodendroglial Tumors

Erin M. Dunbar

Central Nervous System Malignancies

Low-Grade Gliomas

Jimmy Ruiz, Glenn J. Lesser

Genitourinary Cancer

Laparoscopic Radical Cystectomy: Current Status, Outcomes, and Patient Selection

Brian H. Irwin, Inderbir S. Gill, Georges-Pascal Haber, Steven C. Campbell

Genitourinary Cancer

Systemic Therapy of Advanced Urothelial Cancer

Ulka Vaishampayan

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine